HL

Hong Liu

ET Eureka Therapeutics: 3 patents #1 of 16Top 7%
Merck: 2 patents #171 of 961Top 20%
MC Memorial Sloan Kettering Cancer Center: 1 patents #45 of 162Top 30%
📍 Beijing, ME: #1 of 2 inventorsTop 50%
Overall (2019): #35,832 of 560,194Top 7%
5
Patents 2019

Issued Patents 2019

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
10501559 T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLA Nai-Kong V. Cheung, Mahiuddin Ahmed, Andres Lopez-Albaitero, Cheng Liu, Su Yan +1 more 2019-12-10
10464988 Antibody/T-cell receptor chimeric constructs and uses thereof Jingwei Lu, Zhiyuan Yang, Cheng Liu, Yiyang Xu, Su Yan +2 more 2019-11-05
10414774 Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease Jared N. Cumming, Kevin D. Dykstra, Alan Hruza, Derun Li, Haiqun Tang +4 more 2019-09-17
10414775 Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease John P. Caldwell, Mary Ann Caplen, Jared N. Cumming, Kevin D. Dykstra, Alan Hruza +12 more 2019-09-17
10301388 Antibody agents specific for human CD19 and uses thereof Jingwei Lu, Zhiyuan Yang, Li Long, Neal Cheng 2019-05-28